Stereotactic body radiation therapy (SBRT) has emerged as a viable treatment for hepatocellular carcinoma (HCC), particularly for patients with advanced stages. Recognized in clinical guidelines as effective against alternatives like radiofrequency ablation, SBRT demonstrates local control rates of 80-90%. Its role in downstaging unresectable tumors or as a bridge to transplant is gaining traction, with promising results reported when combined with immunotherapy, indicating a need for further randomized studies to solidify SBRT’s positioning in HCC management.
Review by Sharma D, Khosla D (…) Kapoor R et 2 al. in J Clin Exp Hepatol
© 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.